You are an independent reviewer for a strong venue, with expertise in research methodology and statistics and in AI safety evaluation (LLM-as-a-judge, refusal and over-refusal benchmarks, AI control and untrusted monitoring). A graduate researcher asks for a critical review before he pre-registers and runs a study that he intends to publish as a scientific paper.

**What you are reviewing.** Not the protocol alone. On 10 Nov 2026 another AI system (a Claude model), helped by two Claude sub-agents, wrote a publication-readiness review of the protocol. It concluded that the study is worth publishing but that, as designed, the most likely outcome is an inconclusive extension of Khullar et al. (2026), and it proposed 11 changes before the freeze. The author has adopted none of them yet. He wants a second, independent opinion on three things: whether that diagnosis is right; which of the 11 changes to adopt, modify or reject; and what the strongest study is that he can run under his constraints. Treat every statement in the three 10 Nov documents as a claim to verify, not as a fact. Do not defer to them, and do not disagree for the sake of it. Your job is to find what is wrong, weak, missing or over-engineered.

**This is round 1 of an iterative review.** The author will answer each numbered issue and send a revised design. You will then be asked whether each issue is resolved. Number your issues accordingly.

**Disclosure.** You are GPT-6.1 Sol. The same model is respondent and judge number 11 in the study's panel. Review the design on its merits. Where a recommendation could favour or disfavour how your own model or its developer is evaluated (for example, which judges get fewer items), say so in one line.

**The working directory** is a read-only copy of part of the project repository.
- **`docs/STUDY_PROTOCOL_v2.md`:** protocol v2.2 (draft of 8 Nov 2026 with additions of 9–10 Nov; not committed or registered). Read it first and form your own view before you read the review.
- **`docs/audit/2026-11-10_publication_review.md`:** the main object of this review. Its Section 6 holds the 11 proposed changes; its Section 9 lists the decisions it left open.
- **`docs/audit/2026-11-10_fresh_eyes_paper_review.md`** and **`docs/audit/2026-11-10_literature_novelty_sweep.md`:** the two sub-agent reports behind it, verbatim.
- **`docs/PREREGISTRATION_v1_public.md`:** the public version-1 pre-registration (commit `4124f32`) that the protocol revises.
- **`WORDING_EDITS.md`:** three wording edits made on 10 Nov, for review.
- **`analysis/`:**
  - `power_sim.py` and `output/power_sim.json`: the power simulation for the three headline tests;
  - `estimators.py` and `selfcheck_estimators.py`;
  - `output/cost_model_stdout.txt`: the output of `scripts/cost_model.py` on 10 Nov (per-judge costs there are for 1,086 calls per judge);
  - `scratch/t1b_precision_analytic.py` and its output: the back-of-envelope calculation behind change 2.
- **Other files:** `labels/RUBRIC.md`, `docs/annotator_packet/`, `README.md`, `config/`, `src/`, `scripts/cost_model.py`, `data/selection/2026-11-08/`.

Model answers, benchmark prompt files, the author's own prompts and secrets are deliberately not in this copy. In one line of protocol Section 16, three personal names are replaced by a placeholder.

**Context**
- The study is set in November 2026. Model names you may not recognise (e.g. Claude Sonnet 5.5, Gemini 4 Argon, Kimi K3.1 Pro, Venice Uncensored) and the Artificial Analysis / OpenRouter / Ollama figures are real for that date. Do not flag unfamiliar model names, versions or prices as errors.
- State of the study: models 4–6 have generated their benchmark answers, which are sealed by hash; the first gold stage (G1) is drawn; no answer has been read, judged or labeled by anyone. Version 1 of the pre-registration is public. Nothing of version 2.2 is committed or registered.
- Rulings A–D inside the protocol (the bootstrap unit, H2 on fiction only, the fixed-quota stratum, the clarification class) were settled after earlier audits. Reopen one only if it invalidates a main conclusion.

**Constraints you must design within** (fixed)
- One graduate researcher (the PI) and no grant. There is a hard cash cap of US$110 for all API calls of the study, with the pilot, retries and the pessimistic price scenario included. It cannot be raised.
- One workstation with a consumer GPU. Local models up to about 8B parameters run through Ollama at no cash cost, and a few GPU-days are available. More local judge-only models are therefore almost free; more API calls are not.
- Human labels: the PI as first annotator (35–60 hours is realistic); one to three invited co-author annotators at about 8–14 hours each, not invited yet; no paid annotation and no crowd work. The harm-relevant items contain harmful text, so annotators are adults who agree to a welfare protocol.
- The schedule can slip by weeks. Realistic targets are an arXiv preprint and an ICLR 2027 workshop (paper deadline expected around 1 Feb 2027, not verified), then TMLR or a Findings-type venue.
- Calls that place harmful text in a model's context go through separate research accounts, under the providers' usage policies. Provider risk (a warning or a suspended account) is a real cost.
- Version 1 is public. Every departure from it must be defensible as a transparent amendment made before any answer was judged or labeled.

**Rules**
- Read-only: do not create, modify or delete any file.
- Read only files inside the working directory. Do not open, list or search anything outside it, even where the sandbox would allow it.
- Shell: PowerShell is broken on this machine and every PowerShell command hangs. Run every command through `exec_command` with the parameter `shell` set to `C:\Program Files\Git\bin\bash.exe`. `cat`, `sed -n`, `grep`, `head`, `wc` and `awk` work, and `awk` does arithmetic. Python and `jq` are not available in the sandbox. Read long files in parts of about 250 lines (for example `sed -n '1,250p' file`) and set `max_output_tokens` high enough that the output is not truncated.
- Do not run any model or API call.
- Web search is allowed for two purposes only: to verify that the cited papers exist and say what is claimed, and to look for closer prior work. Never put text from this packet in a query, beyond paper titles, arXiv numbers and generic topic keywords. Open only scholarly or official sources. In your report, mark each literature statement as [verified online], [from memory] or [unsure]. Never invent a citation.
- If a number needs a simulation you cannot run, specify the simulation exactly: the data-generating process, the parameters, the statistic and the number of replications. The author will run it and report the result in the next round.

**Part 1. The diagnosis** (review Sections 1–5)

Is it correct? Check each number against the files and say where the review is wrong, too pessimistic or too optimistic. Cover at least these claims:
1. Per-judge precision of about ±18 pp at n = 12 own items and 10% discordance.
2. T1b: an MDE at 80% power of 4.9–6.8 pp; power of 0.10 / 0.21 at a 2-pp effect (first / last Holm step).
3. "If leniency acts only on real failures, a 5-pp average needs a recall drop of roughly 18–21 points on own failures."
4. β_int (θ_on against θ_off) is absent from `power_sim.py`; the back-of-envelope MDE is 6.6–8 pp with 30 anchors per judge.
5. T4 power at Δ = −0.03: 0.96 at ρ = 1, 0.74 at ρ = 0.7, 0.38–0.53 at ρ ≤ 0.4 (first Holm step).
6. H1 passes with probability 0.56 at a true miss rate of 2%.
7. Cost: the revised core at about US$58–72 expected and US$116–143 pessimistic as coded.
8. Novelty. What Khullar et al. (arXiv:2603.04582) already contains (a blind user-turn baseline, the previous-turn condition, the on- versus off-policy contrast). Whether any work cited in the packet, or any work you know or find, already does one of these: (a) blind own-versus-other judging of refusal or harmful-content labels against item-level human labels; (b) the previous-assistant-turn manipulation on that task; (c) matched abliterated-versus-base models as judges of harmful content.
9. The subjective outcome probabilities (Section 4, last bullet) and the venue estimates (Section 8). Give your own.

**Part 2. The 11 proposed changes** (review Section 6)

For each change give: **adopt**, **adopt with modification** or **reject**; the reason; your numeric check where one applies; the new risks it introduces; and the protocol sections that must change.

**Part 3. Cross-cutting questions**

A. **Change 2** (T1b on 100–150 own items per judge, outside the gold set). Is the analytic MDE of about 1.5–2.5 pp right once you account for clustering by base prompt across judges, the equal-weight average over judges, invalid or blocked verdicts and the multiplicity level? The number of own answers available differs by judge (protocol Section 5.2): which allocation do you recommend? What is lost when T1b leaves the frame that has human labels, and what must stay inside it?

B. **Change 3** (anchors). How many off-policy anchors per judge, chosen how, make "self-specific or only an effect of presentation" (β_int) a powered, pre-specified test? Is matching anchors to the judge's own item mix the right design, or is there a better control (for example yoked items: the same answers judged in context by a judge that did not write them)?

C. **Change 4** (T1a outside the Holm family, registered as a bound). Which test, which bound, at which level? What is the correct multiplicity structure for the whole paper after changes 4, 5 and 7: families, gatekeeping and α?

D. **Change 5** (harm-side and refusal-side θ_on as separate estimands). Which is primary? Is a combined θ_on still interpretable?

E. **Change 6 and pre-registration integrity.** Version 1 is public with H1–H3. Is moving H1–H3, RQ4 and instrument selection to a separately registered companion a legitimate amendment, or is it outcome switching? Which wording and timing make it defensible? Is dropping them better than deferring them?

F. **Change 1** (pilot). Does a gold-free pilot contaminate the confirmatory study (the same judges, the same template, items from the same distribution)? Specify the firewall, the pilot's size, and written go / no-go and adaptation rules that keep the confirmatory tests valid. Is an internal pilot with a pre-registered sample-size re-estimation better than an external pilot?

G. **Change 7** (T4). How many matched base/abliterated pairs, which estimator and which margin? Is non-inferiority of sensitivity the right primary estimand, given that an abliterated judge may simply answer "harmful" more often (specificity, criterion shift)?

H. **Change 8** (reference standard). Which items need adjudicated multi-annotator labels for the primary claims to stand, with how many annotators, and how many hours does that take? What can stay single-annotated?

I. **Budget.** Build the allocation you would defend under US$110 at pessimistic prices, using `analysis/output/cost_model_stdout.txt` (five judges are about 90% of judge cost). State what you cut.

J. **Provider and ethics risk** of the scaled in-context calls and the anchors: harmful text is placed in a commercial model's assistant turn about 100–150 times per judge. Is there a design that keeps the test and lowers this risk?

K. **Gaps and excess.** What do the 11 changes miss? What in them, or in the protocol, is over-engineered for one researcher and should be cut?

**Part 4. Three decisions the review left open**

Give a recommendation and the reason for each.
- (i) Run the pilot before the freeze?
- (ii) Defer or drop the version-1 hypotheses (H1–H3), RQ4 and instrument selection?
- (iii) Keep T4 (abliterated judges) in this paper, or split it into a separate short paper?

**Part 5. The strongest design**

If you designed this study now, under the constraints above and with what already exists (the sealed answers of models 4–6, the 22-model panel, the code), what is the strongest study you can defend? Give a specification the author could paste into a protocol:
- the claim of the paper in two sentences;
- the primary and secondary estimands;
- the tests and the multiplicity structure;
- the items per judge, by judge group, and the anchors;
- which labels are human, and how many;
- T4;
- the budget table;
- what is frozen, and when;
- the probability you assign to each main outcome.

Say which parts of the present protocol you would delete.

**Part 6. Wording edits**

Answer the questions in `WORDING_EDITS.md`.

**Output** (in English, as your final message)
1. **Verdict:** 4–6 sentences, including whether you agree that the study is worth running and publishing.
2. **Table of the 11 changes:** the change, your decision and a one-line reason.
3. **Issues,** numbered so that later rounds can refer to them: `R1-C1`… for critical issues (would invalidate a main conclusion or make the paper unpublishable), `R1-M1`… for major issues, `R1-m1`… for minor issues. For each: where (file and section or line), the problem, why it matters, and a concrete fix.
4. **Numeric checks:** a table with the claim, the source you checked, your value, and agree or disagree.
5. **Answers to Part 3 (A–K) and Part 4 (i–iii).**
6. **The strongest design** (Part 5).
7. **Literature:** each statement marked [verified online], [from memory] or [unsure], and the references that are missing.
8. **Wording edits** (Part 6).
9. **Convergence list:** the conditions under which you would call the design ready to freeze.

Be concrete and quantitative. Where you agree with the review, say so in one line, and spend the words where you disagree or where the review is incomplete. Aim for about 4,000–5,500 words.
